FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/01/062068 [Registered on: 30/01/2024] Trial Registered Prospectively
Last Modified On: 12/01/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Other 
Public Title of Study   Etiology, Complications & Outcome of Patients with Illnesses of Lungs in Patients Admitted in a Pediatric Intensive Care Unit. 
Scientific Title of Study   Etiology, Complications & Outcome of Patients with Respiratory Illnesses Admitted to a Tertiary Care Pediatric Intensive Care Unit. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Milind S Tullu 
Designation  Professor Additional  
Affiliation  Seth G.S. Medical College and KEM Hospital 
Address  Department of Pediatrics, Seth G.S. Medical College and KEM Hospital, Old KEM Hospital Building, Ward No. 1, Parel, Mumbai.

Mumbai
MAHARASHTRA
400012
India 
Phone  9869469974  
Fax    
Email  milindtullu@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Milind S Tullu 
Designation  Professor Additional  
Affiliation  Seth G.S. Medical College and KEM Hospital 
Address  Department of Pediatrics, Seth G.S. Medical College and KEM Hospital, Old KEM Hospital Building, Ward No. 1, Parel, Mumbai.


MAHARASHTRA
400012
India 
Phone  9869469974  
Fax    
Email  milindtullu@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Suprita Sunitkumar Khedekar  
Designation  Junior Resident 
Affiliation  Seth G.S. Medical College and KEM Hospital 
Address  Department of Pediatrics, Seth G.S. Medical College and KEM Hospital, Old KEM Hospital Building, Ward No. 1, Parel, Mumbai.

Mumbai
MAHARASHTRA
400012
India 
Phone  9423079675  
Fax    
Email  supreetakhedekar02@gmail.com  
 
Source of Monetary or Material Support  
Seth G S Medical College and KEM Hospital, Parel, Mumbai 400012, Maharashtra, INDIA 
 
Primary Sponsor  
Name  NIL 
Address  NIL 
Type of Sponsor  Other [NIL] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Milind S Tullu  Seth G.S. Medical College and KEM Hospital  Pediatric Intensive Care Unit, Old Hospital Building, Ward No. 1, Ground Floor, Parel, Mumbai 400012, MAHARASHTRA, India
Mumbai
MAHARASHTRA 
9869469974

milindtullu@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee IEC III, Seth GS Medical College and KEM Hospital, Mumbai  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J189||Pneumonia, unspecified organism, (2) ICD-10 Condition: J989||Respiratory disorder, unspecified, (3) ICD-10 Condition: J22||Unspecified acute lower respiratory infection,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  1.00 Month(s)
Age To  12.00 Year(s)
Gender  Both 
Details  All consecutive patients admitted to the PICU with the diagnosis of a respiratory illness from the age group of 1 month to 12 years of either gender will be enrolled in the study. 
 
ExclusionCriteria 
Details  1.Patients whose parent or guardian refuse to give informed consent,
2.Patients admitted with non respiratory illnesses who develop a new respiratory illness after 48 hours admission to PICU and
3.Patients admitted for non respiratory illness or post-trauma cases or post operative cases developing respiratory complications during their PICU stay and patients with tachypnea due to metabolic acidosis.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
For the patients admitted to a tertiary care Pediatric Intensive Care Unit (PICU) with a respiratory illness--
1. Etiology of the respiratory illness,
2. Indication for admission to the PICU,
3. Final outcome, survival or death, and
4. Predictors of mortality
 
At discharge from the Pediatric intensive care
unit or at death of the patient. 
 
Secondary Outcome  
Outcome  TimePoints 
For the patients admitted to a tertiary care Pediatric Intensive Care Unit (PICU) with a respiratory illness--
1. Co-morbidities,
2. Complications, and
3. Need for mechanical ventilation (non invasive or invasive) and duration of the ventilation.
 
At discharge from the Pediatric intensive care
unit or at death of the patient. 
 
Target Sample Size   Total Sample Size="152"
Sample Size from India="152" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/02/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Aims & Objectives:

The aims and objectives of this study are-

Primary objectives:

For the patients admitted to a tertiary care Pediatric Intensive Care Unit (PICU) with a respiratory illness, to determine the --

1. Etiology of the respiratory illness

2. Indication for admission to the PICU

3. Final outcome (survival/death)

4. Predictors of mortality

Secondary Objectives:

For the patients admitted to a tertiary care Pediatric Intensive Care Unit (PICU) with a respiratory illness, to determine the --

1. Co-morbidities

2. Complications

3. Need for mechanical ventilation (non-invasive/invasive) & duration of the ventilation.

Materials & Methods:

Ethics: The study will be initiated after seeking approval from the “Institutional Ethics Committee (IEC)” of the hospital. The study will be conducted in compliance with the “Ethical Guidelines for Biomedical Research on Human Participants” by the Indian Council of Medical Research.

Consent & Assent: Case enrollment will be done after a written informed consent from the parent/ guardian. Since patients in the PICU are critically ill, the assent will be procured from children aged 7 years and above once the clinical condition stabilizes and when they are in a position to give the assent.

Study design: Prospective, non-interventional, observational, single centre study.

Study duration: The study will be conducted over a period of 12 months (prospectively) after approval from the IEC. Each patient will be in the study till his/her stay in the PICU.

Study site: The study will be conducted in patients admitted to the PICU of KEM hospital, Mumbai, which is a tertiary care, 14-bedded PICU with state-of-art facilities including mechanical ventilators, non-invasive monitors and other devices for delivering critical care. It is manned by at least 4 resident medical officers round the clock. One Additional Professor looks after the day-to-day clinical and administrative matters of the PICU and is assisted by one Associate Professor and one Assistant Professor. Fellows (MUHS) and senior registrars are also posted in the PICU (when available).

Inclusion Criteria: All consecutive patients admitted to the PICU with the diagnosis of a respiratory illness from the age group of 1 month to 12 years of either gender will be enrolled in the study.

Exclusion Criteria:

The following patients will be excluded from this study-

1. Patients whose parent/ guardian refuse to give informed consent.

2. Patients admitted with non-respiratory illnesses who develop a new respiratory illness after 48 hours admission to PICU.

3. Patients admitted for non-respiratory illness/post-trauma cases/ post-operative cases developing respiratory complications during their PICU stay and patients with tachypnea due to metabolic acidosis.

Confidentiality:The participant’s details will not be disclosed at any point of time.

Total number of patients to be studied (sample size calculation):

It has been noticed that the average number of admissions to the Pediatric ICU is around 400 per year. Of these, about 20% patients are expected to have primary respiratory illnesses.24 

So, taking e as 0.05; p = 0.2 , N = 400 & z = 1.96, the sample size is calculated to be 152.

Z = 1.96; p = Prevalence of respiratory illnesses in PICU setting = 20% = 0.2; N = Number of PICU admissions in 12 months = 400; e = Margin of error = 0.05.

Sample size calculation:

(1.96*1.96) * 0.2 (1-0.2)

--------------------------------------

0.05 * 0.05

————————————————-

1 + (1.96*1.96) * 0.2 (1-0.2)

--------------------------------------

0.05 * 0.05 * 500

= 152

Study Procedure & Data Recording:

The patient’s daily medical records will be scrutinized from admission until discharge from PICU or until death of the patient or transfer to the pediatric ward, whichever is earlier. Readmission of the same patient to PICU will be counted as a separate case enrolled. This study will not entail performing any new/ additional investigation or new/ additional treatment or any new/ additional financial burden to the hospital or financial burden to the parent/ guardian.

Following data/ information will be recorded in a pre-designed case record form- CRF (from the patient’s hospital case sheets/ indoor medical papers)-

·       Demographic details: age (in months), sex, weight, socio-economic status, duration of PICU stay (less than/ equal to 7 days & more than 7 days) and hospital stay (less than/ equal to 14 days & more than 14 days).

·       Clinical Details: Indication of PICU admission, Final complete diagnosis (with etiology of the respiratory illness), Ventilation related data with duration (invasive/ non-invasive/ both), co-morbidities (severe malnutrition, incomplete immunization for the given age, cardiac illness, respiratory malformations, gastroesophageal reflux- GER, other organ failure, etc) & complications (Recorded in Yes/ No format for the following parameters- pleural effusion, empyema, shock, sepsis, ventilator associated pneumonia- VAP, nosocomial blood stream infection, and thrombocytopenia).

·       Outcome: Final outcome of the patient (survival/ death/ discharge taken against medical advice i.e. DAMA with survival at discharge), length of PICU stay and length of hospital stay.

·       Predictors of mortality: The factors which will be analyzed for their effect on mortality will include-- age, sex, malnutrition, socio-economic status- Kuppuswanmy scale, severity of illness (PIM 2 score), etiology of respiratory illness, need for ventilation (invasive mechanical ventilation/ non-invasive mechanical ventilation/ both types), total duration of ventilation in hours, presence of co-morbidities, occurrence of complications, duration of PICU stay (less than/ equal to 7 days and more than 7 days)& duration of hospital stay (less than/ equal to 14 days & more than 14 days).

·       Predictors of Length of Stay (LOS) i.e. PICU stay (less than/ equal to 7 days and more than 7 days)& duration of hospital stay (less than/ equal to 14 days & more than 14 days): The factors which will be analyzed for their effect on LOS will include-- age, sex, malnutrition, socio-economic status- Kuppuswanmy scale, severity of illness (PIM 2 score), etiology of respiratory illness, need for ventilation (invasive mechanical ventilation/ non-invasive mechanical ventilation/ both types), total duration of ventilation in hours, presence of co-morbidities, and occurrence of complications.

Plan for Statistical Analysis:

The following statistical tests will be applied for the various variables and their analysis--

1. The etiology of the respiratory illness, indication for PICU admission, need for ventilation, type of ventilation (invasive/ non-invasive), co-mobidities, complications & final outcome will be listed as percentage of total patients enrolled.

2. Age, weight, duration of PICU stay & duration of hospital stay will be expressed as mean, standard deviation, median and mode.

3. Predictors of mortality will be analyzed by chi-square test (p<0.05 will be considered as statistically significant). Regression analysis will be done for the factors which are found to be significant by univariate analysis.

Expected Outcomes:

This study will help --

1.   To understand the etiology & different types of respiratory illnesses requiring PICU admission and their outcome.

2.   To rationalize the resources and in framing admission and discharge policy for the patients in PICU.


References :

1. Dahan M, Gelb A. The identity target in the post-2015 development agenda. Center for Global Development 2015. Available from: http://www.cgdev.org/sites/default/files/CGD-Essay-Dahan-Gelb-Role-Identification-Post-2015-ID4D_0.pdf [Last accessed on August 04, 2023.

2. Hasan MM, Saha KK, Yunus RM, Alam K. Prevalence of acute respiratory infections among children in India: Regional inequalities and risk factors. Maternal and Child Health Journal 2022;26:1594-1602.

3. Murarkar S, Gothankar J, Doke P, Dhumale G, Pore PD, Lalwani S et al. Prevalence of the acute respiratory infections and associated factors in the rural areas and urban slum areas of Western Maharashtra, India: A Community-Based Cross-Sectional Study. Front. Public Health 2021;9:723807.

4. NFHS-5 Factsheet2019-2020. Available from: http://rchiips.org/nfhs/NFHS-5_FCTS/FactSheet_MH.pdf[Last accessed on August 04 2023].

5. Islam F, Sarma R, Debroy A, Kar S, Pal R. Profiling acute respiratory tract infections in children from Assam, India. J Glob Infect Dis2013;5:8-14.

6.Walke SP, Das R, Acharya AS, Pemde HK. Incidence, pattern and severity of acute respiratory infections among infants and toddlers of a peri-urban area of Delhi: A 12-month prospective study. Int Sch Res Notices2014; 2014:165152.

7.Dorofaeff T, Mohseni-Bod H, Cox PN. Infections in the PICU. In: Elzouki AY, Harfi HA, Nazer HM, Stapleton B, Oh W, Whitley RJ(eds). Textbook of Clinical Paediatrics. Springer-Verlag Berlin Heidelberg: Springer Science & Business Media, Heidelberg. 2nd edition; 2012:2537-2563.

8.  Pneumonia in children. Geneva: World Health Organisation 2022. Available from http://www.who.int/news-room/fact-sheets/detail/pneumonia [Last accessed on  August 04 2023].

9. Chandy S, Manoharan A, Hameed A, Jones LK,  Nachiyar GS, Ramya MS et al. A study on pediatric respiratory tract infections in hospitalised children from Chennai. Clinical Epidemiology and Global Health 2022;15:101067

10.Suhasini M, Sardarsulthana SA, Manjuleswari N,Radhika. Study of pattern of respiratory illnesses admitted to PICU in children 1 month- 5 years: Indian Journal of Applied Research 2015;5:601-605.

11. Das S, Ray SK, Mukherjee M, Maitra A, Chatterjee K, Sen S. Epidemiology of admissions with respiratory illnesses: a single tertiary centre experience. Int J Contemp Pediatr 2017;4:378-382.

12. Revised WHO classification and treatment of childhood pneumonia at health facilities: Evidence Summaries.Geneva: World Health Organisation 2014. Available from http://apps.who.int/iris/bitstream/handle/10665/137319/9789241507813_eng.pdf [Last accessed on  August 04 2023].

13. Bronchiolitis in children: diagnosis and management.National Institute for Health and Care Excellence 2015.  Available from www.nice.org.uk/guidance/ng9. [Last accessed on August 04 2023 ].

14. Al-Eyadhy AA, Temsah MH, Alhaboob AA, Aldubayan AK, Alangari MI, Alshaya AM . Asthma changes at a paediatric intensive care unit after 10 years: Observational study. Ann Thorac Med 2015;10:243-248.

15.Bhandar R, Patil S, Kumar S. A study of clinical profile and outcome of children admitted with respiratory distress in a tertiary care centre. Medpulse International Journal of Pediatrics 2020;16:68-74.

16. Divecha C, Tullu MS, Chaudhary S. Burden of respiratory illnesses in pediatric intensive care unit and predictors of mortality: Experience from a low resource country. Pediatric Pulmonology 2019;54:1234-1241.

17.Maheshwari K, Sharma N. Clinical profile and outcome of patients admitted to pediatric intensive care unit in a tertiary care teaching hospital of Puducherry, India. Int J Contemp Pediatr 2020;7:1280-1283.

18.Moyen E, Kambourou J, Okoko AR, Nguelongo LB, Bomelefa-Bomel V, Nkounkou KG, et al. Child acute lower respiratory tract infection in Pediatric Intensive Care unit  at University Hospital of Brazzaville (Congo). Open Journal of Pediatrics 2018;8:32-41.

19. Hutton HK, Zar HJ, Argent AC. Features and outcome of children with severe lower respiratory tract infection admitted to a Pediatric Intensive Care Unit in South Africa. J Trop Pediatr 2019;65:46-54.

20. Singh J, Bhardwar V, Sobti P, Pooni PA. Clinical profile and outcome of acute respiratory failure in children: A prospective study in a tertiary care hospital. International  Journal of Clinical Pediatrics 2014;3:46-50.

21. Duyu M, Karakaya Z. Viral etiology and outcome of severe lower respiratory tract infections among critically ill children admitted to the PICU. Med Intensiva (Engl Ed) 2021;45:447-458.

22. Ghimire P, Gachhadar R, Piya N, Shreshtha K. Prevalence and factors associated with acute respiratory infection among under-five children in selected tertiary hospitals of Kathmandu Valley. PLoS ONE 2022;17:e0265933.

23. Kumar AMK, Badakali AV, Mirji G, Vanaki RN, Pol R. Clinical profile and outcome of acute lower respiratory tract infection in children aged between 2 months to 5 years. Int J Contemp Pediatr 2017;4:105-109.

 

 

 

 
Close